Talk:Pharmaceutical marketing

This is the talk page for discussing improvements to the Pharmaceutical marketing article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Archives: Index, 1: 90 days

Marketing & Advertising Low‑importance

	This article is within the scope of WikiProject Marketing & Advertising, a collaborative effort to improve the coverage of Marketing on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Marketing & AdvertisingWikipedia:WikiProject Marketing & AdvertisingTemplate:WikiProject Marketing & AdvertisingMarketing & Advertising articles
Low	This article has been rated as Low-importance on the importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Pharmacology High‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
High	This article has been rated as High-importance on the project's importance scale.

Marketing budget "far exceeds" R&D

I hear this claim a lot, but the sources given don't link to a primary source of info. One commonly cited source on the web is this BBC article, but it no longer shows the table: https://www.bbc.com/news/business-28212223 ...but I found the data at archive.org: https://web.archive.org/web/20141119101441/https://www.bbc.com/news/business-28212223 As a source, it just says a GlobalData study, but no link.

This article relies on industry self-reporting (though the data was given to Congress, so probably isn't an outright lie): https://www.raps.org/news-and-articles/news-articles/2019/7/do-biopharma-companies-really-spend-more-on-market

I've removed these references:

NYT link doesn't say anything about R&D vs marketing spending: https://www.nytimes.com/2015/12/20/opinion/sunday/no-justification-for-high-drug-prices.html
This source https://pubmed.ncbi.nlm.nih.gov/18982834/ cites https://www.nejm.org/doi/full/10.1056/NEJMp058136 (Waxman) as the source of 'marketing over R&D', but that article just states how much is spent relative to medical education: "The pharmaceutical industry spends more than $5.5 billion to promote drugs to doctors each year — more than what all U.S. medical schools spend to educate medical students. Major drug companies employ about 90,000 sales representatives — one for every 4.7 doctors in the United States, according to the American Medical Association."
The text of this is behind a paywall: https://pubmed.ncbi.nlm.nih.gov/18713478/

Also, the Skeptical Inquirer link is only available to subscribers: https://skepticalinquirer.org/2018/03/drug-therapy-hype-the-misuse-of-data/

More review and sources would be good. (I forgot to sign my comment.) Unclevinny (talk) 19:37, 15 December 2022 (UTC)[reply]

4.2 plagiarism

While I do not have any better information, the first three paragraphs of section "Regulation and fraud", subsection "United States", are lifted almost verbatim from the New York Times. As a student attempting to find more information, it was frustrating to not only use another computer to circumvent the paywall, but to also find the exact same text I had just read. 163.11.62.69 (talk) 16:28, 12 December 2022 (UTC)[reply]

Wiki Education assignment: Research Process and Methodology - FA23 - Sect 202 - Thu

This article was the subject of a Wiki Education Foundation-supported course assignment, between 6 September 2023 and 14 December 2023. Further details are available on the course page. Student editor(s): ChrisMisu (article contribs).

— Assignment last updated by ChrisMisu (talk) 02:38, 17 November 2023 (UTC)[reply]

Substantial improvement needed

This page is IMHO currently missing the most fundamental criteria of quality and objectivity of information. The incipit used to be not a definition of the term, as it should be.

Furthermore, the information included in the page is currently US-centric, while any breadth of information about pharma marketing practices in other parts of the world are missing.

Finally, the choice of sources is IMHO weak and contentious.

I'm going to have this substantially improved. Ferdinando Scala (talk) 17:57, 12 December 2023 (UTC)[reply]

Copyright violation

Special:Diff/421943370 copies from another place. An inline citation to a reference that also have that part (as quotation from another report, which I can't find access) has later been added. It is still unquoted in the current version. It is also dated by "last year", but I can't fix it since I don't know the publication year of the original source. Naruyoko (talk) 20:50, 4 November 2024 (UTC)[reply]